quality of investors - next science also had. its not an indicator of revenue, just the ability of wealthy to park cash in a zero rate environment.
They had FDA clearance in early 2019 as per below. It has resulted in zero revenue to date.
This company is all talk and hype but actual delivery of revenue is quite difficult when dealing with hospital budgets.
Research, page-142
-
- There are more pages in this discussion • 2,864 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 4DX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
57.0¢ |
Change
0.005(0.88%) |
Mkt cap ! $234.0M | |||
| Open | High | Low | Value | Volume |
| 57.0¢ | 58.0¢ | 56.5¢ | $188.0K | 327.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1964 | 57.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 58.5¢ | 48675 | 2 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| 4DX (ASX) Chart |